Brookfield (BN) Financials

$46.52 +0.07 (+0.16%)

Closing price 03:59 PM Eastern

Extended Trading

$46.21 -0.31 (-0.67%)

As of 07:24 PM Eastern

Annual Income Statements for Brookfield

This table shows Brookfield's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	5,025	7,640	11,392	8,210	-134	3,966	10,390	10,210	641
Consolidated Net Income / (Loss)	3,338	4,551	7,488	5,354	3,419	12,388	5,195	5,105	1,853
Net Income / (Loss) Continuing Operations	3,338	4,551	7,488	5,663	3,419	12,388	7,251	6,235	1,853
Total Pre-Tax Income	1,700	3,951	6,152	6,158	4,256	14,712	6,107	5,178	106
Total Operating Income	4,581	5,958	8,046	12,931	10,763	11,615	16,192	15,576	17,994
Total Gross Profit	6,693	8,398	11,252	17,905	9,441	11,731	16,314	15,645	18,070
Total Revenue	24,411	40,786	56,771	70,633	62,618	75,731	94,825	97,054	86,006
Operating Revenue	24,411	40,786	56,771	70,633	62,752	75,731	94,825	97,054	86,006
Total Cost of Revenue	17,718	32,388	45,519	52,728	53,177	64,000	78,511	81,409	67,936
Operating Cost of Revenue	17,718	32,388	45,519	52,728	53,177	64,000	78,511	81,409	67,936
Total Operating Expenses	2,112	2,440	3,206	4,974	-1,322	116	122	69	76
Selling, General & Admin Expense	92	95	104	98	101	116	122	69	76
Total Other Income / (Expense), net	-2,881	-2,007	-1,894	-6,773	-6,507	3,097	-10,085	-10,398	-17,888
Interest Expense	3,233	3,608	4,854	7,227	7,213	5,153	10,702	15,503	16,615
Other Income / (Expense), net	352	1,601	2,960	454	785	8,250	617	5,105	-1,273
Income Tax Expense	-345	613	-248	495	837	2,324	1,469	1,011	982
Other Gains / (Losses), net	1,293	1,213	1,088	-	-	-	2,613	2,068	2,729
Net Income / (Loss) Attributable to Noncontrolling Interest	-1,687	-3,089	-3,904	-2,547	-841	-8,422	-3,139	-3,975	-1,212
Weighted Average Basic Shares Outstanding	-	1.37	3.47	1.78	-0.12	-	1.22	0.62	0.31
Diluted Earnings per Share	$1.55	$1.34	$3.40	$1.73	($0.12)	$2.39	$1.19	$0.61	$0.31

This table shows Brookfield's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	441	495	544	581	620	724
Consolidated Net Income / (Loss)	373	518	537	507	584	692
Net Income / (Loss) Continuing Operations	373	518	537	507	584	692
Total Pre-Tax Income	444	660	633	582	659	770
Total Operating Income	436	583	641	579	533	757
Total Gross Profit	800	956	1,079	935	1,074	1,272
Total Revenue	861	892	1,114	1,048	1,073	1,226
Operating Revenue	861	892	1,114	1,048	1,073	1,226
Total Cost of Revenue	61	-64	35	113	-1.00	-46
Operating Cost of Revenue	61	-64	35	113	-1.00	-46
Total Operating Expenses	364	373	438	356	541	515
Selling, General & Admin Expense	360	368	430	343	504	489
Other Operating Expenses / (Income)	4.00	5.00	8.00	13	37	26
Total Other Income / (Expense), net	8.00	77	-8.00	3.00	126	13
Interest & Investment Income	80	53	61	58	181	110
Other Income / (Expense), net	-72	24	-69	-55	-55	-97
Income Tax Expense	71	142	96	75	75	78
Preferred Stock Dividends Declared	-	-6.00	-60	-	-99	-165
Net Income / (Loss) Attributable to Noncontrolling Interest	-68	29	53	-74	63	133
Basic Earnings per Share	-	$0.31	$0.34	-	$0.38	$0.45
Weighted Average Basic Shares Outstanding	-	1.60B	1.61B	1.61B	1.61B	1.61B
Diluted Earnings per Share	-	$0.31	$0.34	-	$0.38	$0.44
Weighted Average Diluted Shares Outstanding	-	1.61B	1.62B	1.61B	1.63B	1.63B
Weighted Average Basic & Diluted Shares Outstanding	-	-	-	1.61B	1.61B	1.61B

This table details how cash moves in and out of Brookfield's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	1,519	796	3,462	-1,600	3,166	3,090	1,561	-3,368	4,505
Net Cash From Operating Activities	-10,845	4,005	5,159	6,328	-8,341	7,874	8,751	6,467	7,569
Net Cash From Continuing Operating Activities	-10,845	4,005	5,159	6,328	8,341	7,874	8,751	6,467	7,569
Net Income / (Loss) Continuing Operations	3,338	4,551	7,488	5,354	707	12,388	5,195	5,105	1,853
Consolidated Net Income / (Loss)	3,338	4,551	7,488	5,354	707	12,388	5,195	5,105	1,853
Depreciation Expense	2,020	2,345	3,102	4,876	5,791	6,437	7,683	9,075	9,737
Non-Cash Adjustments To Reconcile Net Income	33,151	-2,082	-3,254	-2,108	1,985	-8,943	-972	-5,546	632
Changes in Operating Assets and Liabilities, net	-558	-809	-2,177	-1,794	-142	-2,008	-3,155	-2,167	-4,653
Net Cash From Investing Activities	-10,849	-11,394	-19,833	-36,674	-13,873	-21,045	-39,650	-29,762	-29,964
Net Cash From Continuing Investing Activities	-10,849	-11,394	-19,833	-36,674	-13,873	-21,045	-39,650	-29,762	-29,964
Purchase of Property, Plant & Equipment	-	-3,804	-4,841	-9,974	-9,123	-18,167	-16,900	-16,282	-22,313
Acquisitions	-	-10,336	-22,269	-31,088	-3,453	-14,559	-26,306	-12,922	-6,453
Purchase of Investments	-	-2,718	-953	-5,534	-3,733	-3,708	-5,142	-10,492	-7,074
Sale of Property, Plant & Equipment	1,537	2,972	5,098	5,379	2,391	6,942	4,469	2,748	6,880
Divestitures	9,442	2,834	1,729	2,336	3,415	5,952	6,325	5,688	1,049
Sale and/or Maturity of Investments	-	889	2,163	1,725	215	1,711	1,645	3,258	1,087
Other Investing Activities, net	-	-1,231	-760	482	-3,585	784	-3,741	-1,760	-3,140
Net Cash From Financing Activities	-2,330	8,185	18,136	28,746	8,698	16,261	32,460	19,927	26,900
Net Cash From Continuing Financing Activities	-2,330	8,082	18,239	28,746	9,100	16,261	32,603	20,237	25,361
Repayment of Debt	-	-21,598	-25,437	-44,060	-36,300	-60,107	-55,569	-78,122	-87,582
Repurchase of Common Equity	-	-131	-406	-283	0.00	-368	-686	-646	-1,001
Payment of Dividends	2,796	-5,592	-7,435	-9,340	-7,360	-9,649	-12,131	-13,444	-8,478
Issuance of Debt	1,272	27,954	44,843	65,780	40,041	83,088	90,189	85,174	113,324
Issuance of Common Equity	-	256	11	13	0.00	23	14	49	19
Other Financing Activities, net	-	7,193	6,663	16,636	12,719	3,274	10,786	27,226	9,079
Cash Interest Paid	3,062	3,374	4,712	6,323	6,583	7,001	9,009	13,902	14,289
Cash Income Taxes Paid	371	402	980	504	1,101	1,116	1,079	1,677	2,674

This table details how cash moves in and out of Brookfield's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Net Change in Cash & Equivalents	-231	-728	-1,114	-511	390	771
Net Cash From Operating Activities	516	393	567	265	378	752
Net Cash From Continuing Operating Activities	355	327	486	-173	621	1,483
Net Income / (Loss) Continuing Operations	373	518	537	507	584	692
Consolidated Net Income / (Loss)	373	518	537	507	584	692
Depreciation Expense	4.00	3.00	4.00	3.00	11	16
Non-Cash Adjustments To Reconcile Net Income	156	-92	-187	-358	76	679
Changes in Operating Assets and Liabilities, net	-178	-102	132	-325	-50	96
Net Cash From Investing Activities	-6.00	-452	-1,323	84	-339	-8.00
Net Cash From Continuing Investing Activities	-6.00	-452	-1,323	84	-339	-434
Purchase of Property, Plant & Equipment	-3.00	-124	122	-2.00	-1.00	-4.00
Purchase of Investments	0.00	-391	-1,459	-11	-522	-207
Other Investing Activities, net	-3.00	63	263	-116	154	-38
Net Cash From Financing Activities	-580	-603	-277	-422	108	-168
Net Cash From Continuing Financing Activities	-580	-603	-277	-422	108	-284
Repurchase of Common Equity	0.00	-	-	-116	-	-69
Payment of Dividends	-622	-659	-628	-710	-710	-695
Issuance of Debt	0.00	-	-	235	515	750
Other Financing Activities, net	42	56	351	154	114	-256
Cash Interest Paid	2.00	7.00	4.00	12	38	26
Cash Income Taxes Paid	91	103	66	96	32	67

This table presents Brookfield's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	159,826	192,720	256,281	323,969	343,696	391,003	3,161	3,205	14,157
Total Current Assets	13,432	17,112	25,321	25,247	18,928	34,454	3,161	895	3,387
Cash & Equivalents	4,299	5,139	8,390	6,778	-	12,694	1.00	9.00	404
Accounts Receivable	9,133	11,973	16,931	18,469	18,928	21,760	782	886	2,983
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	-193,217	0.00	0.00	0.00	0.00
Total Noncurrent Assets	146,394	175,608	230,960	298,722	318,851	356,549	0.00	2,310	10,770
Long-Term Investments	24,977	31,994	33,647	40,698	41,327	46,100	-	-	251
Noncurrent Deferred & Refundable Income Taxes	1,562	1,464	2,732	3,572	3,338	3,340	-	-	586
Other Noncurrent Operating Assets	109,567	120,986	164,819	208,690	234,814	244,315	0.00	2,310	9,933
Total Liabilities & Shareholders' Equity	159,826	192,720	256,281	323,969	384,813	391,003	3,161	3,205	14,157
Total Liabilities	90,138	112,848	159,131	207,123	262,171	256,262	784	1,120	2,966
Total Current Liabilities	12,042	19,389	24,801	44,767	243,899	231,626	781	1,120	2,441
Accounts Payable	11,915	17,965	23,989	43,077	50,682	52,546	781	1,120	2,441
Total Noncurrent Liabilities	78,096	93,459	134,330	162,356	18,272	24,636	0.00	0.00	525
Long-Term Debt	64,891	78,389	118,218	143,375	-	-	-	-	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	9,640	11,409	12,236	14,849	15,913	20,328	-	-	46
Other Noncurrent Operating Liabilities	3,565	3,661	3,876	4,132	-	4,308	-	-	479
Commitments & Contingencies	-	-	-	-	-	-	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	-	2,103
Total Equity & Noncontrolling Interests	69,688	79,872	97,150	116,846	122,642	134,741	2,377	2,085	9,088
Total Preferred & Common Equity	26,453	79,872	97,150	116,846	122,642	134,741	2,377	2,076	8,752
Total Common Equity	26,453	79,872	97,150	116,846	122,642	134,741	2,377	2,076	8,752
Common Stock	26,453	-	-	-	-	-	2,688	2,757	9,169
Retained Earnings	-	-	-	-	-	-	19	-35	-488
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	-	0.00	3.00	162
Other Equity Adjustments	-	79,872	97,150	116,846	-	-	-330	-	-91
Noncontrolling Interest	43,235	-	-	-	-	-	0.00	9.00	336

This table presents Brookfield's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q4 2023	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	12/31/2022	12/31/2023	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Total Assets	441,284	490,095	490,424	14,966	16,143	16,521
Total Current Assets	41,774	39,734	45,269	4,164	4,398	4,843
Cash & Equivalents	14,396	11,222	15,051	332	480	1,062
Accounts Receivable	27,378	28,512	30,218	3,832	3,918	3,781
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	399,510	450,361	445,155	10,802	11,745	11,678
Long-Term Investments	47,094	59,124	68,310	422	744	0.00
Noncurrent Deferred & Refundable Income Taxes	3,403	3,338	3,723	613	647	702
Other Noncurrent Operating Assets	279,110	311,505	291,029	9,767	10,354	10,976
Total Liabilities & Shareholders' Equity	441,284	490,095	490,424	14,966	16,143	16,521
Total Liabilities	299,393	321,853	325,041	4,073	5,113	5,847
Total Current Liabilities	57,941	59,011	60,223	3,035	3,347	3,394
Accounts Payable	57,065	58,893	55,502	3,035	3,347	3,394
Total Noncurrent Liabilities	241,452	262,842	264,818	1,038	1,766	2,453
Long-Term Debt	214,074	233,710	234,792	235	743	1,486
Noncurrent Deferred & Payable Income Tax Liabilities	23,190	24,987	25,267	97	114	121
Other Noncurrent Operating Liabilities	4,188	4,145	4,759	706	909	846
Commitments & Contingencies	-	-	-	-	-	0.00
Redeemable Noncontrolling Interest	-	-	-	1,930	1,859	1,562
Total Equity & Noncontrolling Interests	141,891	168,242	165,383	8,963	9,171	9,112
Total Preferred & Common Equity	141,891	168,242	165,383	8,489	8,470	8,461
Total Common Equity	141,891	168,242	165,383	8,489	8,470	8,461
Common Stock	-	-	-	9,150	9,209	9,265
Retained Earnings	-	-	-	-617	-715	-704
Accumulated Other Comprehensive Income / (Loss)	-	-	-	176	196	189
Other Equity Adjustments	141,891	168,242	165,383	-220	-220	-289
Noncontrolling Interest	-	-	-	474	701	651

This table displays calculated financial ratios and metrics derived from Brookfield's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	67.08%	39.19%	24.42%	-11.35%	20.94%	25.21%	2.35%	-11.38%
EBITDA Growth	0.00%	42.44%	42.45%	29.44%	-5.05%	51.69%	-6.88%	21.49%	-11.08%
EBIT Growth	0.00%	53.23%	45.60%	21.62%	-13.72%	72.02%	-15.38%	23.04%	-19.15%
NOPAT Growth	0.00%	-8.66%	66.29%	42.07%	-27.29%	13.11%	25.73%	1.93%	-1,286.34%
Net Income Growth	0.00%	36.34%	64.54%	-28.50%	-36.14%	262.33%	-58.06%	-1.73%	-63.70%
EPS Growth	0.00%	-13.55%	153.73%	-28.50%	-36.14%	262.33%	-50.21%	-48.74%	-49.18%
Operating Cash Flow Growth	0.00%	136.93%	28.81%	22.66%	-231.81%	194.40%	11.14%	-26.10%	17.04%
Free Cash Flow Firm Growth	0.00%	0.00%	-290.65%	36.48%	775.47%	-207.49%	81.11%	34.92%	-440.61%
Invested Capital Growth	0.00%	15.19%	42.18%	22.67%	-82.63%	563.40%	20.34%	12.55%	-5.46%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	27.42%	20.59%	19.82%	25.35%	15.08%	15.49%	17.20%	16.12%	21.01%
EBITDA Margin	28.48%	24.28%	24.85%	25.85%	27.69%	34.73%	25.83%	30.66%	30.76%
Operating Margin	18.77%	14.61%	14.17%	18.31%	17.19%	15.34%	17.08%	16.05%	20.92%
EBIT Margin	20.21%	18.53%	19.39%	18.95%	18.44%	26.23%	17.73%	21.31%	19.44%
Profit (Net Income) Margin	13.67%	11.16%	13.19%	7.58%	5.46%	16.36%	5.48%	5.26%	2.15%
Tax Burden Percent	196.35%	115.19%	121.72%	86.94%	80.33%	84.20%	85.07%	98.59%	1,748.11%
Interest Burden Percent	34.46%	52.27%	55.90%	46.01%	36.85%	74.06%	36.33%	25.04%	0.63%
Effective Tax Rate	-20.29%	15.52%	-4.03%	8.04%	19.67%	15.80%	24.05%	19.52%	926.42%
Return on Invested Capital (ROIC)	5.25%	4.46%	5.72%	6.21%	6.98%	6.99%	4.59%	4.03%	-46.44%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.90%	3.19%	4.19%	-1.53%	-122.32%	30.35%	-0.89%	-0.74%	51.69%
Return on Net Nonoperating Assets (RNNOA)	-0.46%	1.63%	2.74%	-1.21%	-4.13%	2.63%	-0.84%	-0.74%	47.55%
Return on Equity (ROE)	4.79%	6.09%	8.46%	5.00%	2.86%	9.63%	3.76%	3.29%	1.11%
Cash Return on Invested Capital (CROIC)	0.00%	-9.66%	-29.12%	-14.15%	147.79%	-140.61%	-13.87%	-7.78%	-40.82%
Operating Return on Assets (OROA)	3.09%	4.29%	4.90%	4.61%	3.46%	5.41%	4.04%	4.44%	3.41%
Return on Assets (ROA)	2.09%	2.58%	3.34%	1.85%	1.02%	3.37%	1.25%	1.10%	0.38%
Return on Common Equity (ROCE)	1.82%	4.33%	8.46%	5.00%	2.86%	9.63%	3.76%	3.29%	1.11%
Return on Equity Simple (ROE_SIMPLE)	12.62%	5.70%	7.71%	4.58%	2.79%	9.19%	3.66%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	5,511	5,034	8,370	11,892	8,646	9,780	12,297	12,535	-148,705
NOPAT Margin	22.57%	12.34%	14.74%	16.84%	13.81%	12.91%	12.97%	12.92%	-172.90%
Net Nonoperating Expense Percent (NNEP)	6.15%	1.26%	1.52%	7.74%	129.31%	-23.36%	5.49%	4.77%	-98.13%
Return On Investment Capital (ROIC_SIMPLE)	4.09%	3.18%	3.89%	4.57%	2.74%	3.15%	3.45%	3.12%	-37.16%
Cost of Revenue to Revenue	72.58%	79.41%	80.18%	74.65%	84.92%	84.51%	82.80%	83.88%	78.99%
SG&A Expenses to Revenue	0.38%	0.23%	0.18%	0.14%	0.16%	0.15%	0.13%	0.07%	0.09%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.65%	5.98%	5.65%	7.04%	-2.11%	0.15%	0.13%	0.07%	0.09%
Earnings before Interest and Taxes (EBIT)	4,933	7,559	11,006	13,385	11,548	19,865	16,809	20,681	16,721
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6,953	9,904	14,108	18,261	17,339	26,302	24,492	29,756	26,458
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.26	0.19	0.25	0.39	0.58	0.36	0.26	0.38
Price to Tangible Book Value (P/TBV)	0.00	0.34	0.27	0.40	0.58	0.93	0.68	0.46	0.67
Price to Revenue (P/Rev)	0.00	0.51	0.33	0.42	0.77	1.03	0.54	0.45	0.73
Price to Earnings (P/E)	0.00	2.72	1.62	3.62	0.00	19.72	4.88	4.24	97.44
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.71%	0.56%
Earnings Yield	0.00%	36.81%	61.67%	27.63%	0.00%	5.07%	20.48%	23.57%	1.03%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.51	0.55	0.60	5.47	0.80	0.70	0.63	0.69
Enterprise Value to Revenue (EV/Rev)	0.00	1.52	1.67	1.78	3.20	2.58	2.14	2.13	2.49
Enterprise Value to EBITDA (EV/EBITDA)	0.00	6.26	6.71	6.88	11.55	7.43	8.30	6.95	8.08
Enterprise Value to EBIT (EV/EBIT)	0.00	8.20	8.60	9.38	17.34	9.83	12.10	9.99	12.79
Enterprise Value to NOPAT (EV/NOPAT)	0.00	12.32	11.31	10.56	23.16	19.98	16.53	16.49	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	15.48	18.35	19.85	0.00	24.81	23.23	31.96	28.26
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	1.09	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.93	0.98	1.22	1.23	1.58	1.31	1.51	1.39	1.42
Long-Term Debt to Equity	0.93	0.98	1.22	1.23	0.00	0.00	1.51	1.39	1.42
Financial Leverage	0.51	0.51	0.65	0.79	0.03	0.09	0.94	1.00	0.92
Leverage Ratio	2.29	2.36	2.54	2.71	2.79	2.85	3.01	3.00	2.94
Compound Leverage Factor	0.79	1.23	1.42	1.25	1.03	2.11	1.09	0.75	0.02
Debt to Total Capital	48.22%	49.53%	54.89%	55.10%	61.17%	56.63%	60.14%	58.14%	58.67%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	61.17%	56.63%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	48.22%	49.53%	54.89%	55.10%	0.00%	0.00%	60.14%	58.14%	58.67%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	32.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	19.66%	50.47%	45.11%	44.90%	38.83%	43.37%	39.86%	41.86%	41.33%
Debt to EBITDA	9.33	7.91	8.38	7.85	11.14	6.69	8.74	7.85	8.87
Net Debt to EBITDA	5.12	4.17	5.40	5.25	8.76	4.45	6.23	5.49	5.72
Long-Term Debt to EBITDA	9.33	7.91	8.38	7.85	0.00	0.00	8.74	7.85	8.87
Debt to NOPAT	11.78	15.57	14.12	12.06	22.35	17.99	17.41	18.64	-1.58
Net Debt to NOPAT	6.46	8.20	9.10	8.06	17.57	11.98	12.41	13.03	-1.02
Long-Term Debt to NOPAT	11.78	15.57	14.12	12.06	0.00	0.00	17.41	18.64	-1.58
Altman Z-Score	0.00	0.44	0.44	0.37	-0.38	-0.06	0.40	0.37	0.37
Noncontrolling Interest Sharing Ratio	62.04%	28.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	1.12	0.88	1.02	0.56	0.08	0.15	0.72	0.67	0.75
Quick Ratio	1.12	0.88	1.02	0.56	0.08	0.15	0.72	0.67	0.75
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-10,915	-42,641	-27,083	182,939	-196,649	-37,155	-24,179	-130,714
Operating Cash Flow to CapEx	0.00%	481.37%	0.00%	137.71%	-123.90%	70.15%	70.40%	47.78%	49.04%
Free Cash Flow to Firm to Interest Expense	0.00	-3.03	-8.78	-3.75	25.36	-38.16	-3.47	-1.56	-7.87
Operating Cash Flow to Interest Expense	-3.35	1.11	1.06	0.88	-1.16	1.53	0.82	0.42	0.46
Operating Cash Flow Less CapEx to Interest Expense	-2.88	0.88	1.12	0.24	-2.09	-0.65	-0.34	-0.46	-0.47
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.15	0.23	0.25	0.24	0.19	0.21	0.23	0.21	0.18
Accounts Receivable Turnover	2.67	3.86	3.93	3.99	3.35	3.72	3.86	3.47	2.93
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	1.49	2.17	2.17	1.57	1.13	1.24	1.43	1.40	1.19
Days Sales Outstanding (DSO)	136.56	94.44	92.92	91.47	108.99	98.05	94.57	105.10	124.62
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	245.46	168.37	168.21	232.13	321.77	294.36	254.79	259.95	307.31
Cash Conversion Cycle (CCC)	-108.90	-73.93	-75.29	-140.66	-212.78	-196.31	-160.22	-154.86	-182.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	104,998	120,947	171,958	210,933	36,640	243,069	292,521	329,235	311,244
Invested Capital Turnover	0.23	0.36	0.39	0.37	0.51	0.54	0.35	0.31	0.27
Increase / (Decrease) in Invested Capital	0.00	15,949	51,011	38,975	-174,293	206,429	49,452	36,714	-17,991
Enterprise Value (EV)	0.00	62,010	94,654	125,611	200,290	195,365	203,323	206,684	213,889
Market Capitalization	0.00	20,754	18,473	29,712	48,400	78,227	50,739	43,320	62,458
Book Value per Share	$0.00	$58,300,729,927.01	$101.33	$122.33	$121.89	$89.19	$116,304,098,360.66	$271,358,064,516.13	$533,493,548,387.10
Tangible Book Value per Share	$0.00	$44,024,087,591.24	$72.56	$78.09	$82.76	$55.54	$61,326,229,508.20	$152,156,451,612.90	$301,874,193,548.39
Total Capital	134,579	158,261	215,368	260,221	315,859	310,673	355,965	401,952	400,175
Total Debt	64,891	78,389	118,218	143,375	193,217	175,932	214,074	233,710	234,792
Total Long-Term Debt	64,891	78,389	118,218	143,375	0.00	0.00	214,074	233,710	234,792
Net Debt	35,615	41,256	76,181	95,899	151,890	117,138	152,584	163,364	151,431
Capital Expenditures (CapEx)	-1,537	832	-257	4,595	6,732	11,225	12,431	13,534	15,433
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2,909	-7,416	-7,870	-26,298	-31,754	-33,934	-30,563	-30,499	-30,005
Debt-free Net Working Capital (DFNWC)	1,390	-2,277	520	-19,520	-31,754	-21,240	-16,167	-19,277	-14,954
Net Working Capital (NWC)	1,390	-2,277	520	-19,520	-224,971	-197,172	-16,167	-19,277	-14,954
Net Nonoperating Expense (NNE)	2,173	483	882	6,538	5,227	-2,608	7,102	7,430	-150,558
Net Nonoperating Obligations (NNO)	35,310	41,075	74,808	94,087	-86,002	108,328	150,630	160,993	145,861
Total Depreciation and Amortization (D&A)	2,020	2,345	3,102	4,876	5,791	6,437	7,683	9,075	9,737
Debt-free, Cash-free Net Working Capital to Revenue	-11.92%	-18.18%	-13.86%	-37.23%	-50.71%	-44.81%	-32.23%	-31.42%	-34.89%
Debt-free Net Working Capital to Revenue	5.69%	-5.58%	0.92%	-27.64%	-50.71%	-28.05%	-17.05%	-19.86%	-17.39%
Net Working Capital to Revenue	5.69%	-5.58%	0.92%	-27.64%	-359.28%	-260.36%	-17.05%	-19.86%	-17.39%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$1.11	$0.00	$0.00	$0.00	$0.00	$1.22	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	1.18B	4.00	3.00	0.00	3.00	0.00	1.00	0.00
Adjusted Diluted Earnings per Share	$0.00	$1.09	$2.77	$2.12	($0.10)	$1.94	$1.19	$0.41	$0.21
Adjusted Weighted Average Diluted Shares Outstanding	0.00	1.18B	1.17B	1.24B	1.86B	0.00	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	1.18B	1.17B	1.24B	1.86B	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	3,207	5,034	5,632	11,892	8,646	9,780	12,297	12,535	12,596
Normalized NOPAT Margin	13.14%	12.34%	9.92%	16.84%	13.81%	12.91%	12.97%	12.92%	14.65%
Pre Tax Income Margin	6.96%	9.69%	10.84%	8.72%	6.80%	19.43%	6.44%	5.34%	0.12%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.53	2.10	2.27	1.85	1.60	3.86	1.57	1.33	1.01
NOPAT to Interest Expense	1.70	1.40	1.72	1.65	1.20	1.90	1.15	0.81	-8.95
EBIT Less CapEx to Interest Expense	2.00	1.86	2.32	1.22	0.67	1.68	0.41	0.46	0.08
NOPAT Less CapEx to Interest Expense	2.18	1.16	1.78	1.01	0.27	-0.28	-0.01	-0.06	-9.88
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-83.76%	122.87%	99.29%	174.45%	215.27%	77.89%	233.51%	263.35%	457.53%
Augmented Payout Ratio	-83.76%	125.75%	104.71%	179.73%	215.27%	80.86%	246.72%	276.00%	511.55%

This table displays calculated financial ratios and metrics derived from Brookfield's official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	21.72%	20.29%	10.05%
EBITDA Growth	0.00%	0.00%	0.00%	43.21%	-19.84%	17.36%
EBIT Growth	0.00%	0.00%	0.00%	43.96%	-21.25%	15.38%
NOPAT Growth	0.00%	0.00%	0.00%	37.71%	3.23%	25.11%
Net Income Growth	0.00%	0.00%	0.00%	35.92%	12.74%	28.86%
EPS Growth	0.00%	0.00%	0.00%	0.00%	22.58%	29.41%
Operating Cash Flow Growth	0.00%	0.00%	0.00%	-48.64%	-3.82%	32.63%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Revenue Q/Q Growth	0.00%	3.60%	24.89%	0.00%	2.39%	14.26%
EBITDA Q/Q Growth	0.00%	65.76%	-5.57%	0.00%	-7.21%	38.24%
EBIT Q/Q Growth	0.00%	66.76%	-5.77%	0.00%	-8.78%	38.08%
NOPAT Q/Q Growth	0.00%	24.92%	18.84%	0.00%	-6.35%	44.03%
Net Income Q/Q Growth	0.00%	38.87%	3.67%	0.00%	15.19%	18.49%
EPS Q/Q Growth	0.00%	0.00%	9.68%	0.00%	0.00%	15.79%
Operating Cash Flow Q/Q Growth	0.00%	-23.84%	44.27%	0.00%	42.64%	98.94%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-2.10%	-3.38%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	1.69%	5.20%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	92.92%	107.17%	96.86%	89.22%	100.09%	103.75%
EBITDA Margin	42.74%	68.39%	51.71%	50.29%	45.57%	55.14%
Operating Margin	50.64%	65.36%	57.54%	55.25%	49.67%	61.75%
EBIT Margin	42.28%	68.05%	51.35%	50.00%	44.55%	53.83%
Profit (Net Income) Margin	43.32%	58.07%	48.20%	48.38%	54.43%	56.44%
Tax Burden Percent	84.01%	78.48%	84.83%	87.11%	88.62%	89.87%
Interest Burden Percent	121.98%	108.73%	110.66%	111.07%	137.87%	116.67%
Effective Tax Rate	15.99%	21.52%	15.17%	12.89%	11.38%	10.13%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.62%	2.07%	3.60%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	-0.39%	-44.36%	9.11%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.02%	1.93%	0.36%
Return on Equity (ROE)	0.00%	0.00%	0.00%	0.64%	4.00%	3.96%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.22%	0.68%	1.17%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.22%	0.84%	1.23%
Return on Common Equity (ROCE)	0.00%	0.00%	0.00%	0.50%	3.07%	3.14%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	7.95%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	366	458	544	504	472	680
NOPAT Margin	42.54%	51.30%	48.81%	48.13%	44.02%	55.49%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	0.00%	1.01%	46.43%	-5.51%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	5.48%	4.76%	6.42%
Cost of Revenue to Revenue	7.08%	-7.17%	3.14%	10.78%	-0.09%	-3.75%
SG&A Expenses to Revenue	41.81%	41.26%	38.60%	32.73%	46.97%	39.89%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	42.28%	41.82%	39.32%	33.97%	50.42%	42.01%
Earnings before Interest and Taxes (EBIT)	364	607	572	524	478	660
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	368	610	576	527	489	676
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	9.34	10.52	10.86
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	9.34	10.52	10.86
Price to Revenue (P/Rev)	0.00	0.00	0.00	1,184.00	359.45	255.14
Price to Earnings (P/E)	0.00	0.00	0.00	116.49	110.60	93.16
Dividend Yield	3.30%	3.80%	3.18%	3.26%	2.96%	2.97%
Earnings Yield	0.00%	0.00%	0.00%	0.86%	0.90%	1.07%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	7.83	8.65	8.51
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	1,212.13	367.83	262.47
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	712.39	1,425.34	524.94
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	712.39	1,425.34	524.94
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	712.39	1,425.34	524.94
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	215.99	252.69	173.06
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.02	0.07	0.14
Long-Term Debt to Equity	0.00	0.00	0.00	0.02	0.07	0.14
Financial Leverage	0.00	0.00	0.00	-0.05	-0.04	0.04
Leverage Ratio	0.00	0.00	0.00	1.37	1.46	1.55
Compound Leverage Factor	0.00	0.00	0.00	1.53	2.02	1.81
Debt to Total Capital	0.00%	0.00%	0.00%	2.11%	6.31%	12.22%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	2.11%	6.31%	12.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	21.60%	21.74%	18.20%
Common Equity to Total Capital	0.00%	0.00%	0.00%	76.29%	71.94%	69.58%
Debt to EBITDA	0.00	0.00	0.00	2.06	11.61	8.26
Net Debt to EBITDA	0.00	0.00	0.00	-4.55	-7.52	2.36
Long-Term Debt to EBITDA	0.00	0.00	0.00	2.06	11.61	8.26
Debt to NOPAT	0.00	0.00	0.00	2.06	11.61	8.26
Net Debt to NOPAT	0.00	0.00	0.00	-4.55	-7.52	2.36
Long-Term Debt to NOPAT	0.00	0.00	0.00	2.06	11.61	8.26
Altman Z-Score	0.00	0.00	0.00	11.84	10.59	9.62
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	22.07%	23.21%	20.73%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	0.00	0.00	1.37	1.31	1.43
Quick Ratio	0.00	0.00	0.00	1.37	1.31	1.43
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	0.00	-9,870	-10,077	-10,418
Operating Cash Flow to CapEx	17,200.00%	316.94%	0.00%	13,250.00%	37,800.00%	18,800.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.02	0.02
Accounts Receivable Turnover	0.00	0.00	0.00	0.02	0.06	0.10
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.02	0.03	0.01
Days Sales Outstanding (DSO)	0.00	0.00	0.00	20,875.82	5,766.41	3,833.51
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	21,303.37	10,623.09	36,435.59
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	-427.54	-4,856.68	-32,602.07
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	0.00	0.00	10,374	10,549	11,098
Invested Capital Turnover	0.00	0.00	0.00	0.01	0.05	0.06
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	10,374	10,549	11,098
Enterprise Value (EV)	0.00	0.00	0.00	81,213	91,222	94,489
Market Capitalization	16,785	15,227	18,964	79,328	89,143	91,852
Book Value per Share	$0.00	$0.00	$0.00	$5.18	$5.25	$5.25
Tangible Book Value per Share	$0.00	$0.00	$0.00	$5.18	$5.25	$5.25
Total Capital	0.00	0.00	0.00	11,128	11,773	12,160
Total Debt	0.00	0.00	0.00	235	743	1,486
Total Long-Term Debt	0.00	0.00	0.00	235	743	1,486
Net Debt	0.00	0.00	0.00	-519	-481	424
Capital Expenditures (CapEx)	3.00	124	-122	2.00	1.00	4.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	0.00	0.00	797	571	387
Debt-free Net Working Capital (DFNWC)	0.00	0.00	0.00	1,129	1,051	1,449
Net Working Capital (NWC)	0.00	0.00	0.00	1,129	1,051	1,449
Net Nonoperating Expense (NNE)	-6.72	-60	6.79	-2.61	-112	-12
Net Nonoperating Obligations (NNO)	0.00	0.00	0.00	-519	-481	424
Total Depreciation and Amortization (D&A)	4.00	3.00	4.00	3.00	11	16
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	1,189.55%	230.24%	107.50%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	1,685.07%	423.79%	402.50%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	1,685.07%	423.79%	402.50%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.38	$0.45
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	1.61B	1.61B	1.61B
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.38	$0.44
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	1.61B	1.63B	1.63B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	1.61B	1.61B	1.61B
Normalized Net Operating Profit after Tax (NOPAT)	366	458	544	504	472	680
Normalized NOPAT Margin	42.54%	51.30%	48.81%	48.13%	44.02%	55.49%
Pre Tax Income Margin	51.57%	73.99%	56.82%	55.53%	61.42%	62.81%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	106.37%	103.78%	93.30%
Augmented Payout Ratio	0.00%	0.00%	0.00%	106.37%	103.78%	93.30%

Financials Breakdown Chart

Key Financial Trends

Here are notable trends for Brookfield Corp (BN) based on the quarterly cash flow, income statement, and balance sheet data over the last four years provided. The focus is on identifying cash flow durability, earnings progression, and liquidity signals that may matter to retail investors.

Rising net income to common shareholders in 2025: Net income attributable to common shareholders reached about $724 million in Q3 2025, up from around $544 million in Q3 2024, indicating improving profitability at the core level.
Earnings per share improving in 2025: Q3 2025 basic EPS about $0.45 and diluted EPS about $0.44, with roughly 1.613 billion shares outstanding, signaling solid per‑share profitability as earnings grow.
Robust operating cash flow in Q3 2025: Net cash from continuing operating activities was about $1.483 billion, underscoring strong cash generation from ongoing operations.
Liquidity improving through 2025: Cash and cash equivalents stood around $1.062 billion by Q3 2025, reflecting an improving liquidity position.
Low near-term capex supports cash generation: Purchase of property, plant & equipment in Q3 2025 was only about $4 million, leaving more cash available for operations, debt service, or returns to shareholders.
Sizable and steady dividend payouts: Quarterly dividends remain substantial, consistent with a shareholder‑friendly policy that supports income-focused investors.
Financing activities show near-term cash outflows: Net cash from financing activities was negative in Q3 2025, reflecting ongoing dividend outlays and debt management; this reduces cash in the near term but is common for learners-focused yield stories.
Balance sheet balance tilted toward a stronger equity base: The latest period shows a solid equity cushion relative to liabilities, suggesting a prudent balance sheet structure for a diversified assets manager.
Asset mix expanding with noncurrent assets: Noncurrent assets and long-term investments increased over the period, aligning with Brookfield’s growth and diversification strategy; this can raise long-term depreciation/impairment considerations but supports future cash flow potential.
Liquidity and financing sensitivity in certain quarters: Quarterly cash balances and financing activity can swing, and periods of cash outflows from financing (dividends, debt management) may pressure liquidity if operating performance falters.

05/07/26 07:29 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Brookfield's Financials

When does Brookfield's fiscal year end?

According to the most recent income statement we have on file, Brookfield's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Brookfield's net income changed over the last 8 years?

Brookfield's net income were at $1.85 billion at the end of 2024, a 63.7% decrease from 2023, and a 44.5% decrease since 2016. View Brookfield's forecast to see where analysts expect Brookfield to go next.

What is Brookfield's operating income?

Brookfield's total operating income in 2024 was $17.99 billion, based on the following breakdown:

Total Gross Profit: $18.07 billion
Total Operating Expenses: $76 million

How has Brookfield's revenue changed over the last 8 years?

Over the last 8 years, Brookfield's total revenue changed from $24.41 billion in 2016 to $86.01 billion in 2024, a change of 252.3%.

How much debt does Brookfield have?

Brookfield's total liabilities were at $2.97 billion at the end of 2024, a 164.8% increase from 2023, and a 96.7% decrease since 2016.

How much cash does Brookfield have?

In the past 8 years, Brookfield's cash and equivalents has ranged from $0.00 in 2020 to $12.69 billion in 2021, and is currently $404 million as of their latest financial filing in 2024.

How has Brookfield's book value per share changed over the last 8 years?

Over the last 8 years, Brookfield's book value per share changed from 0.00 in 2016 to 533,493,548,387.10 in 2024, a change of 53,349,354,838,709.7%.

Related Companies

Financial statements for NYSE:BN last updated on 11/10/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Brookfield (BN) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Brookfield's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Brookfield (BN) Financials

Annual Income Statements for Brookfield

Quarterly Income Statements for Brookfield

Annual Cash Flow Statements for Brookfield

Quarterly Cash Flow Statements for Brookfield

Annual Balance Sheets for Brookfield

Quarterly Balance Sheets for Brookfield

Annual Metrics And Ratios for Brookfield

Quarterly Metrics And Ratios for Brookfield

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Brookfield's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools